Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

BackgroundMultiple myeloma (MM) is a highly heterogeneous disease with enormously variable outcomes. It remains to be a major challenge to conduct a more precise estimation of the survival of MM patients. The existing stratifications attached less importance to the prognostic significance of comorbi...

Full description

Bibliographic Details
Main Authors: Shuangshuang Jia, Lei Bi, Yuping Chu, Xiao Liu, Juan Feng, Li Xu, Tao Zhang, Hongtao Gu, Lan Yang, Qingxian Bai, Rong Liang, Biao Tian, Yaya Gao, Hailong Tang, Guangxun Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
prognostic model
risk stratification
HCT-CI
comorbidity
multiple myeloma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.805702/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.805702/full

Similar Items